Trelagliptin relieved cognitive impairment of diabetes mellitus rats: Involvement of PI3K/Akt/GSK-3β and inflammation pathway
Cognitive impairment frequently coexists with diabetes. Trelagliptin is a once-weekly taking selective dipeptidyl peptidase-4 (DPP-4) inhibitor and a long-term effective hypoglycemic medicine; nonetheless, its effects for the treatment of diabetes-related cognitive impairment have only sometimes bee...
Main Authors: | Min Lei, Xiying Guo, Yue Yao, Ting Shu, Zhanhong Ren, Xiaosong Yang, Changhan Ouyang, Qingjie Chen, Chao Liu, Xiufen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Experimental Gerontology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0531556523002280 |
Similar Items
-
Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
by: Xiying Guo, et al.
Published: (2023-08-01) -
“Olfactory three-needle” acupuncture enhances synaptic function in A𝜷1-42-induced Alzheimer’s disease via activating PI3K/AKT/GSK-3𝜷 signaling pathway
by: Yuan Wang, et al.
Published: (2021-03-01) -
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
by: Ningning Guo, et al.
Published: (2024-08-01) -
Neurological functions of the masterswitch protein kinase – GSK-3
by: Oksana eKaidanovich-Beilin, et al.
Published: (2012-04-01) -
BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation
by: Jialu Xu, et al.
Published: (2025-01-01)